ID   NDF2_HUMAN              Reviewed;         382 AA.
AC   Q15784; Q8TBI7; Q9UQC6;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   30-MAY-2000, sequence version 2.
DT   07-APR-2021, entry version 168.
DE   RecName: Full=Neurogenic differentiation factor 2;
DE            Short=NeuroD2;
DE   AltName: Full=Class A basic helix-loop-helix protein 1;
DE            Short=bHLHa1;
DE   AltName: Full=NeuroD-related factor;
DE            Short=NDRF;
GN   Name=NEUROD2; Synonyms=BHLHA1, NDRF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=8816493; DOI=10.1128/mcb.16.10.5792;
RA   McCormick M.B., Tamimi R.M., Snider L., Asakura A., Bergstrom D.,
RA   Tapscott S.J.;
RT   "NeuroD2 and neuroD3: distinct expression patterns and transcriptional
RT   activation potentials within the neuroD gene family.";
RL   Mol. Cell. Biol. 16:5792-5800(1996).
RN   [2]
RP   SEQUENCE REVISION TO 336-338.
RA   Tapscott S.J., Tamimi R.T., McCormick B.M.;
RL   Submitted (JUL-1998) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10209266; DOI=10.1016/s0167-4781(99)00038-x;
RA   Kitamura T., Miyachi T., Nakamura S., Kawakami H.;
RT   "Identification and analysis of the promoter region of the human NeuroD-
RT   related factor (NDRF).";
RL   Biochim. Biophys. Acta 1445:142-147(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INVOLVEMENT IN DEE72, AND VARIANTS DEE72 GLN-130 AND THR-134.
RX   PubMed=30323019; DOI=10.1136/jmedgenet-2018-105322;
RA   Sega A.G., Mis E.K., Lindstrom K., Mercimek-Andrews S., Ji W., Cho M.T.,
RA   Juusola J., Konstantino M., Jeffries L., Khokha M.K., Lakhani S.A.;
RT   "De novo pathogenic variants in neuronal differentiation factor 2 (NEUROD2)
RT   cause a form of early infantile epileptic encephalopathy.";
RL   J. Med. Genet. 56:113-122(2019).
CC   -!- FUNCTION: Transcriptional regulator implicated in neuronal
CC       determination. Mediates calcium-dependent transcription activation by
CC       binding to E box-containing promoter. Critical factor essential for the
CC       repression of the genetic program for neuronal differentiation;
CC       prevents the formation of synaptic vesicle clustering at active zone to
CC       the presynaptic membrane in postmitotic neurons. Induces transcription
CC       of ZEB1, which in turn represses neuronal differentiation by down-
CC       regulating REST expression. Plays a role in the establishment and
CC       maturation of thalamocortical connections; involved in the segregation
CC       of thalamic afferents into distinct barrel domains within layer VI of
CC       the somatosensory cortex. Involved in the development of the cerebellar
CC       and hippocampal granular neurons, neurons in the basolateral nucleus of
CC       amygdala and the hypothalamic-pituitary axis. Associates with chromatin
CC       to the DPYSL3 E box-containing promoter (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with TCF3, TCF4 and TCF12. Interacts with CDC20.
CC       Efficient DNA-binding and transcription activation require dimerization
CC       with another bHLH protein (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00981}.
CC   -!- DOMAIN: The C-terminal region is necessary for depolarization-induced
CC       and calcium-dependent transcription activation. {ECO:0000250}.
CC   -!- DISEASE: Developmental and epileptic encephalopathy 72 (DEE72)
CC       [MIM:618374]: A form of epileptic encephalopathy, a heterogeneous group
CC       of severe early-onset epilepsies characterized by refractory seizures,
CC       neurodevelopmental impairment, and poor prognosis. Development is
CC       normal prior to seizure onset, after which cognitive and motor delays
CC       become apparent. DEE72 is an autosomal dominant form with variable
CC       severity and onset in infancy. {ECO:0000269|PubMed:30323019}. Note=The
CC       disease is caused by variants affecting the gene represented in this
CC       entry.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U58681; AAC26058.1; -; Genomic_DNA.
DR   EMBL; AB021742; BAA77569.1; -; mRNA.
DR   EMBL; BC022481; AAH22481.1; -; mRNA.
DR   CCDS; CCDS11338.1; -.
DR   PIR; G02668; G02668.
DR   RefSeq; NP_006151.3; NM_006160.3.
DR   SMR; Q15784; -.
DR   BioGRID; 110834; 4.
DR   IntAct; Q15784; 3.
DR   MINT; Q15784; -.
DR   STRING; 9606.ENSP00000306754; -.
DR   iPTMnet; Q15784; -.
DR   PhosphoSitePlus; Q15784; -.
DR   BioMuta; NEUROD2; -.
DR   DMDM; 6226655; -.
DR   MassIVE; Q15784; -.
DR   PaxDb; Q15784; -.
DR   PeptideAtlas; Q15784; -.
DR   PRIDE; Q15784; -.
DR   ProteomicsDB; 60759; -.
DR   Antibodypedia; 16207; 198 antibodies.
DR   DNASU; 4761; -.
DR   Ensembl; ENST00000302584; ENSP00000306754; ENSG00000171532.
DR   GeneID; 4761; -.
DR   KEGG; hsa:4761; -.
DR   UCSC; uc002hry.4; human.
DR   CTD; 4761; -.
DR   DisGeNET; 4761; -.
DR   GeneCards; NEUROD2; -.
DR   HGNC; HGNC:7763; NEUROD2.
DR   HPA; ENSG00000171532; Tissue enriched (brain).
DR   MalaCards; NEUROD2; -.
DR   MIM; 601725; gene.
DR   MIM; 618374; phenotype.
DR   neXtProt; NX_Q15784; -.
DR   OpenTargets; ENSG00000171532; -.
DR   Orphanet; 1934; Early infantile epileptic encephalopathy.
DR   PharmGKB; PA31565; -.
DR   VEuPathDB; HostDB:ENSG00000171532.4; -.
DR   eggNOG; KOG3898; Eukaryota.
DR   GeneTree; ENSGT00940000160871; -.
DR   HOGENOM; CLU_055134_0_1_1; -.
DR   InParanoid; Q15784; -.
DR   OMA; HDMHLHH; -.
DR   OrthoDB; 1096531at2759; -.
DR   PhylomeDB; Q15784; -.
DR   TreeFam; TF315153; -.
DR   PathwayCommons; Q15784; -.
DR   BioGRID-ORCS; 4761; 14 hits in 1003 CRISPR screens.
DR   ChiTaRS; NEUROD2; human.
DR   GeneWiki; NEUROD2; -.
DR   GenomeRNAi; 4761; -.
DR   Pharos; Q15784; Tbio.
DR   PRO; PR:Q15784; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q15784; protein.
DR   Bgee; ENSG00000171532; Expressed in cortical plate and 66 other tissues.
DR   Genevisible; Q15784; HS.
DR   GO; GO:0000785; C:chromatin; ISA:NTNU_SB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IEA:Ensembl.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; ISS:GO_Central.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0070888; F:E-box binding; ISS:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; ISS:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:1990837; F:sequence-specific double-stranded DNA binding; IDA:ARUK-UCL.
DR   GO; GO:0008306; P:associative learning; IEA:Ensembl.
DR   GO; GO:0001662; P:behavioral fear response; IEA:Ensembl.
DR   GO; GO:0071277; P:cellular response to calcium ion; ISS:UniProtKB.
DR   GO; GO:0071257; P:cellular response to electrical stimulus; ISS:UniProtKB.
DR   GO; GO:0021695; P:cerebellar cortex development; ISS:UniProtKB.
DR   GO; GO:2000297; P:negative regulation of synapse maturation; ISS:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; TAS:ProtInc.
DR   GO; GO:0048666; P:neuron development; IEA:Ensembl.
DR   GO; GO:0030182; P:neuron differentiation; IBA:GO_Central.
DR   GO; GO:0050850; P:positive regulation of calcium-mediated signaling; ISS:UniProtKB.
DR   GO; GO:0051091; P:positive regulation of DNA-binding transcription factor activity; ISS:UniProtKB.
DR   GO; GO:0045666; P:positive regulation of neuron differentiation; ISS:UniProtKB.
DR   GO; GO:0090129; P:positive regulation of synapse maturation; ISS:UniProtKB.
DR   GO; GO:0031915; P:positive regulation of synaptic plasticity; ISS:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   Gene3D; 4.10.280.10; -; 1.
DR   InterPro; IPR011598; bHLH_dom.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   InterPro; IPR032649; Neurod2.
DR   InterPro; IPR022575; Neurogenic_DUF.
DR   InterPro; IPR016637; TF_bHLH_NeuroD.
DR   PANTHER; PTHR19290:SF83; PTHR19290:SF83; 1.
DR   Pfam; PF00010; HLH; 1.
DR   Pfam; PF12533; Neuro_bHLH; 1.
DR   PIRSF; PIRSF015618; bHLH_NeuroD; 1.
DR   SMART; SM00353; HLH; 1.
DR   SUPFAM; SSF47459; SSF47459; 1.
DR   PROSITE; PS50888; BHLH; 1.
PE   2: Evidence at transcript level;
KW   Activator; Developmental protein; Differentiation; Disease variant;
KW   DNA-binding; Epilepsy; Neurogenesis; Nucleus; Reference proteome;
KW   Transcription; Transcription regulation.
FT   CHAIN           1..382
FT                   /note="Neurogenic differentiation factor 2"
FT                   /id="PRO_0000127387"
FT   DOMAIN          121..173
FT                   /note="bHLH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00981"
FT   MOTIF           107..113
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        37..46
FT                   /note="Poly-Pro"
FT   COMPBIAS        82..91
FT                   /note="Poly-Glu"
FT   COMPBIAS        282..285
FT                   /note="Poly-Gly"
FT   VARIANT         130
FT                   /note="E -> Q (in DEE72; dbSNP:rs1323339153)"
FT                   /evidence="ECO:0000269|PubMed:30323019"
FT                   /id="VAR_082114"
FT   VARIANT         134
FT                   /note="M -> T (in DEE72; dbSNP:rs1567841596)"
FT                   /evidence="ECO:0000269|PubMed:30323019"
FT                   /id="VAR_082115"
FT   CONFLICT        104
FT                   /note="R -> G (in Ref. 4; AAH22481)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        337..338
FT                   /note="PT -> H (in Ref. 3; BAA77569)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   382 AA;  41361 MW;  E33AA5C0BE371B47 CRC64;
     MLTRLFSEPG LLSDVPKFAS WGDGEDDEPR SDKGDAPPPP PPAPGPGAPG PARAAKPVPL
     RGEEGTEATL AEVKEEGELG GEEEEEEEEE EGLDEAEGER PKKRGPKKRK MTKARLERSK
     LRRQKANARE RNRMHDLNAA LDNLRKVVPC YSKTQKLSKI ETLRLAKNYI WALSEILRSG
     KRPDLVSYVQ TLCKGLSQPT TNLVAGCLQL NSRNFLTEQG ADGAGRFHGS GGPFAMHPYP
     YPCSRLAGAQ CQAAGGLGGG AAHALRTHGY CAAYETLYAA AGGGGASPDY NSSEYEGPLS
     PPLCLNGNFS LKQDSSPDHE KSYHYSMHYS ALPGSRPTGH GLVFGSSAVR GGVHSENLLS
     YDMHLHHDRG PMYEELNAFF HN
//
